Clinical Trials Browser

Phase 2 × OTHER × Peritoneal Neoplasms × Clear all

NCT04779554 2026-04-01

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

Phase 2 Recruiting

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT07282834 2026-02-27

Charlie-2

Phase 2 Recruiting

Neoplasm Metastasis, Neoplasms, Peritoneal Neoplasms

NCT03875144 2026-02-09

MESOTIP

Phase 2 Suspended

Peritoneal Neoplasms

NCT04762953 2026-02-03

STOPGAP

Phase 2 Active not recruiting

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT04107077 2025-10-07

Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

Phase 2 Recruiting

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT03127774 2025-10-03

Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma

Phase 2 Recruiting

EndocrineGynecologic

Peritoneal Neoplasms, Adrenocortical Carcinoma

NCT00766142 2025-08-29

COCHISE

Phase 2 Terminated

18 enrolled 9 charts

GastrointestinalGynecologic

Colonic Neoplasms, Peritoneal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT02040142 2024-10-24

HIPEC for Peritoneal Carcinomatosis

Phase 2 Completed

51 enrolled 12 charts

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

NCT02891447 2024-09-19

Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer

Phase 2 Completed

24 enrolled 10 charts

Peritoneal Neoplasms

NCT05913674 2024-08-21

Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)

Phase 2 Recruiting

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms

NCT05687617 2024-04-02

Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma.

Phase 2 Terminated

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT04840264 2024-03-18

Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction

Phase 2 Recruiting

Peritoneal Neoplasms

NCT05371223 2024-02-26

Nab-PIPAC

Phase 2 Unknown

GastrointestinalGynecologic

Pancreatic Neoplasms, Peritoneal Neoplasms

NCT04826432 2024-02-08

PASIREOCHIP

Phase 2 Terminated

Peritoneal Neoplasms

NCT02399410 2024-01-30

Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis

Phase 2 Completed

GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

NCT02567253 2023-11-27

OvIP1

Phase 2 Completed

Ovarian Neoplasms, Peritoneal Neoplasms

NCT03073694 2023-06-09

Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis

Phase 2 Unknown

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

NCT05541146 2023-03-23

Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis

Phase 2 Unknown

GastrointestinalGynecologic

Carcinoma, Peritoneal Neoplasms, Stomach Neoplasms

NCT01575730 2022-12-15

Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis

Phase 2 Completed

Peritoneal Neoplasms

NCT03287375 2022-10-07

PIPAC-OPC2

Phase 2 Completed

Peritoneal Neoplasms

NCT03280511 2022-10-06

Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients

Phase 2 Recruiting

GastrointestinalGynecologic

Colonic Neoplasms, Peritoneal Neoplasms

NCT05353582 2022-04-29

Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases

Phase 2 Unknown

GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

NCT03352414 2021-08-18

ILEUS

Phase 2 Terminated

84 enrolled 10 charts

Peritoneal Neoplasms, Ileus

NCT04797923 2021-03-15

A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal Dissemination

Phase 2 Unknown

Peritoneal Neoplasms

NCT04734691 2021-02-02

OPAC

Phase 2 Unknown

Peritoneal Neoplasms

NCT03246321 2019-10-15

CRC-PIPAC

Phase 2 Completed

GastrointestinalGynecologic

Appendiceal Neoplasms, Cecal Neoplasms, Intraoperative Complications, Neoplasms, Peritoneal Neoplasms, Postoperative Complications, Colorectal Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT01523678 2019-07-10

Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers

Phase 2 Completed

Uterine Cervical Diseases, Uterine Cervical Neoplasms, Endocrine System Diseases, Fallopian Tube Diseases, Fallopian Tube Neoplasms, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms, Urogenital Neoplasms, Uterine Diseases, Endometrial Neoplasms

NCT03150628 2019-04-17

CISCA

Phase 2 Terminated

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT03161041 2018-11-14

Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis French Part of the Main Bev-IP Study

Phase 2 Withdrawn

Peritoneal Neoplasms

NCT01540344 2018-09-05

COMBATAC

Phase 2 Terminated

GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

NCT01504256 2018-01-23

CatuNeo

Phase 2 Completed

Adenocarcinoma, Peritoneal Neoplasms

NCT02320448 2017-09-12

Treating Peritoneal Carcinomatosis With PIPAC

Phase 2 Completed

Peritoneal Neoplasms

NCT02739698 2017-08-01

Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis From Ovarian Cancer. Hyperthermia Versus Normothermia

Phase 2 Completed

32 enrolled 5 charts

Ovarian Neoplasms, Peritoneal Neoplasms

NCT02638051 2017-05-19

OTMA-RII

Phase 2 Completed

260 enrolled 13 charts

Ascites, Peritoneal Neoplasms, Yin Deficiency, Yang Deficiency

NCT00352755 2016-12-13

A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis

Phase 2 Terminated

18 enrolled 8 charts

Peritoneal Neoplasms

NCT01342653 2016-11-21

HIPEC

Phase 2 Suspended

GastrointestinalGynecologic

Carcinoma, Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms

NCT00112086 2016-08-31

OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT01116791 2015-12-02

Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer

Phase 2 Terminated

GastrointestinalGynecologic

Gastrointestinal Neoplasms, Neoplasms, Peritoneal Neoplasms

NCT02032485 2014-10-15

OC-AP-ICG-IV

Phase 2 Completed

GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

NCT00183794 2014-05-22

Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma

Phase 2 Completed

20 enrolled 8 charts

Ovarian Neoplasms, Peritoneal Neoplasms

NCT01379482 2014-05-06

Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer

Phase 2 Completed

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT00517621 2011-02-25

Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms, Recurrence, Disease Progression

NCT00454519 2009-02-13

IPHC

Phase 2 Unknown

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Neoplasm Metastasis, Peritoneal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT00189345 2006-11-08

Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients

Phase 2 Completed

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms